OR52L2P

Across TCGA pan-cancer cohorts, OR52L2P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated OR52L2P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher OR52L2P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR52L2P expression acts as an unfavorable survival marker.

LIHC, STAD, and THCA are the cancer types where OR52L2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.190	0.788	<.001	90	view →
STAD	OS	Tertile	III,IV	0.381	0.650	.002	72	view →
THCA	DFS	Tertile	All	0.148	0.845	<.001	72	view →
BLCA	DFS	Tertile	All	0.207	0.516	.010	45	view →
PAAD	DFS	Tertile	II,III,IV	0.120	0.452	.003	36	view →
COAD	OS	Tertile	II,III,IV	0.140	0.788	.002	36	view →
UCEC	DFS	Tertile	All	0.555	0.846	<.001	36	view →
LGG	DFS	Tertile	All	0.397	0.744	.001	24	view →
HNSC	OS	Tertile	All	0.416	0.716	.016	18	view →
SARC	DFS	Tertile	All	0.202	0.597	.023	18	view →
SKCM	DFS	Tertile	All	0.416	0.760	.025	6	view →
KIRP	OS	Tertile	All	0.192	0.705	.015	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

OR52L2P–LIHC (OS)

Open the LIHC breakdown →